Marker Therapeutics's total assets for Q4 2025 were $19.07T, an increase of 87743843.71% from the previous quarter. MRKR total liabilities were $2.27T for the fiscal quarter, a 67968394.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.